Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Qingtian Biotechnology is a small private Chinese healthcare-related company focused on pharmaceutical registration support, medical technology development and consulting, and the sale of reference drugs, chemicals, biologic products, and laboratory instruments. Publicly available information indicates that the company operates more as a pharma services, trading, and supply business than as a therapeutic drug developer with a disclosed clinical pipeline. It appears to sell pharmaceutical impurities, research chemicals, and related products through online catalog channels. The company is active in Shenzhen and holds a drug business license according to Chinese business-directory records. Based on the available evidence, Qingtian is relevant to life sciences and healthcare supply, but not clearly a classic venture-backed biotech with novel clinical assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingtian.